Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

Cardiac hypertrophy is a major cause of morbidity and mortality worldwide. The hypertrophic process is mediated, in part, by small G proteins of the Rho family. We hypothesized that statins, inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, inhibit cardiac hypertrophy by blocking Rho isoprenyl...

Cijeli opis

Bibliografski detalji

Izdano u:	J Clin Invest
Glavni autori:	Takemoto, Masao, Node, Koichi, Nakagami, Hironori, Liao, Yulin, Grimm, Michael, Takemoto, Yaeko, Kitakaze, Masafumi, Liao, James K.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Clinical Investigation 2001
Teme:	Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC209420/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714734/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI13350
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!